The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A Randomised, Single-Blind, Placebo-Controlled, Phase IIa Study to Assess the Safety and Tolerability after Multiple Oral Doses of AZD1656 during Four Weeks in T2DM Subjects Treated with Insulin
- collapse Dyslipaemia, atherosclerosis risk and increased hsCRP and inflammatory and oxidative status in the Spanish population
- collapse CEPHEUS- Centralized Pan-European Survey on the undertreatment of hypercholesterolemia. Polish survey on the efficacy of the hypercholesterolemia treatment
- collapse A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIIb Study to Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin and Sulfonylurea in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Combination of Metformin and Sulfonylurea
- collapse A retrospective study of cardiovascular events related to the use of Glucoase lowering drug treatment in Primary Care
- collapse Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
- collapse Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin (SATURN)
- collapse Observational Prospective study to esTIMAte the rates of outcomes in patients undergoing PCI with drug eluting stent (DES) implantation who take statins
- collapse Cardiovascular Risk in General Practice in France: Cardiovascular Risk Week
- collapse Observational non-interventional study – epidemiological survey “AchievemenT of goal resting HEart rate on beta-blockers in patients with stable angiNA and hypertension in routine practice” (ATHENA)
